About Us
A highly experienced management team, supported by world class academic founders and top tier Board.
The Sitryx Team
Leadership Team
An experienced team of drug hunters and developers. Our senior management team have a proven track record of guiding new companies through early inflection points and collectively has overseen 40+ new molecular entities through candidate nomination into development.
Neil WeirCEO
Iain KiltyCSO
Carrie CookChief Business OfficerLisa PierreHead of Early Clinical Development
Jonathan SeniorCFO
Dr. Ravi RaoCMO
Fiona IrvineHead of People and Culture
Scientific Founders
Sitryx was founded by six world leading researchers in the field of immunometabolism, immunology and immunoregulation with the aim of building a biopharmaceutical company focused on the development of disease modifying therapeutics for treating inflammatory disorders and cancer.
Houman AshrafianSV Health Investors
Luke O’Neill FRSTrinity College Dublin
Jonathan PowellJohns Hopkins
Jeff RathmellVanderbilt
Michael RosenblumUCSF
Paul-Peter TakFounder, Independent Director
Board
Top tier, renowned industry leaders.
Pierre LegaultBoard Chairman
Neil WeirCEO
Rich AldrichLongwood Fund
Maina BhamanSofinnova
Nikola TrbovicSV Health Investors
Kate BinghamSV Health Investors
Brad RoblingEli Lilly and Company
Sanne de JonghOxford Science Enterprises
Paul-Peter TakFounder, Independent Director
Rab PrinjhaGSK
Interested in joining the Sitryx team?
We currently have a number of open positions across chemistry and immunology from our lab at the Oxford Science Park.
Discover the openings →